# Mike Florio talks NFL & Danny Parkins previews Cubs for a Cure (Hour 2)

Page: https://stenobird.com/podcast/rahimi-harris-grote-show-387950/mike-florio-talks-nfl-danny-parkins-previews-cubs-for-a-cure-hour-2
Text version: https://stenobird.com/podcast/rahimi-harris-grote-show-387950/mike-florio-talks-nfl-danny-parkins-previews-cubs-for-a-cure-hour-2.md
Podcast: [Rahimi, Harris & Grote Show](https://stenobird.com/podcast/rahimi-harris-grote-show-387950)
Published: 2026-05-20T20:25:00+00:00
Episode link: https://player.amperwavepodcasting.com?feed-link=https%3A%2F%2Frss.amperwave.net%2Fv2%2Fepisode%2F8401012_2026-05-20-190012
Audio file: https://pscrb.fm/rss/p/serve.castfire.com/audio/8401012/8401012_2026-05-20-190012.128.mp3?rssID=3586
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/rahimi-harris-grote-show-387950/episodes/mike-florio-talks-nfl-danny-parkins-previews-cubs-for-a-cure-hour-2
Duration seconds: 2495

## Resource

In the second hour, Leila Rahimi, Marshall Harris and Mark Grote were joined by Mike Florio of Pro Football Talk to discuss the Bears' stadium saga, quarterback Caleb Williams' pursuit of the "Iceman" trademark and more of the latest NFL storylines. After that, FS1 host Danny Parkins joined the show to preview the Cubs for a Cure Radiothon, which will begin Thursday at 10 a.m.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/rahimi-harris-grote-show-387950/episodes/mike-florio-talks-nfl-danny-parkins-previews-cubs-for-a-cure-hour-2/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/rahimi-harris-grote-show-387950/mike-florio-talks-nfl-danny-parkins-previews-cubs-for-a-cure-hour-2.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.